Skip to main content

Shawn Hingtgen, PhD, is a UNC Lineberger Comprehensive Cancer Center member and member of the Molecular Therapeutics research program.

PhD
Associate Professor, Division of Pharmacoengineering and Molecular Pharmaceutics
Clinical Assistant Professor, UNC Department of Neurosurgery
UNC-Chapel Hill
Molecular Therapeutics

Area of Interest

  • Developing tumor-homing stem cell beacons for immune-based cancer therapy.
  • Nanofiber matrices to improve neural stem cell mediated cancer therapy.
  • Engineering stem cell therapies to understand and overcome glioblastoma adaption.

Awards and Honors

  • Keystone Symposia Underrepresent, 2010 
  • American Brain Tumor Association, Post-doctoral Research Fellowship, 2008 
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Minority Travel Award, American Physiological Society, 2005 
  • Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2005 
  • College of Medicine Public Health Research Week Award, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2004
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Minority Travel Award, American Physiological Society, 2004 
  • Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2004 
  • New Investigator Award, Society for Free Radical Biology and Medicine, 2003 
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Minority Travel Award, American Physiological Society, 2003 
  • Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2002 
  • College of Medicine Public Health Research Week Award, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2002 
  • Merck New Investigator Award, American Heart Association Council for High Blood Pressure Research, 2001

Find publications on PubMed

News and Stories